Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Daniel M Jordan
Affiliation
Icahn School of Medicine at Mount Sinai
ORCID
Career Start Year
2007
Papers
31
H Index
18
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36563696
Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts.
Lancet
2023
36563696
Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts.
Lancet
2023
37169741
A machine learning model identifies patients in need of autoimmune disease testing using electronic health records.
Nat Commun
2023
36988189
Phenome-wide Mendelian randomization study of plasma triglyceride levels and 2600 disease traits.
Elife
2023
36988189
Phenome-wide Mendelian randomization study of plasma triglyceride levels and 2600 disease traits.
Elife
2023
37169741
A machine learning model identifies patients in need of autoimmune disease testing using electronic health records.
Nat Commun
2023
35076666
Population-Based Penetrance of Deleterious Clinical Variants.
JAMA
2022
36327219
Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.
PLoS Genet
2022
35987940
A tissue-level phenome-wide network map of colocalized genes and phenotypes in the UK Biobank.
Commun Biol
2022
34951958
Overcoming constraints on the detection of recessive selection in human genes from population frequency data.
Am J Hum Genet
2022
35076666
Population-Based Penetrance of Deleterious Clinical Variants.
JAMA
2022
35987940
A tissue-level phenome-wide network map of colocalized genes and phenotypes in the UK Biobank.
Commun Biol
2022
36327219
Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.
PLoS Genet
2022
34951958
Overcoming constraints on the detection of recessive selection in human genes from population frequency data.
Am J Hum Genet
2022
33499903
Exploiting the GTEx resources to decipher the mechanisms at GWAS loci.
Genome Biol
2021
33493176
Probing the aggregated effects of purifying selection per individual on 1,380 medical phenotypes in the UK Biobank.
PLoS Genet
2021
33483510
An integrative multiomic network model links lipid metabolism to glucose regulation in coronary artery disease.
Nat Commun
2021
33499903
Exploiting the GTEx resources to decipher the mechanisms at GWAS loci.
Genome Biol
2021
33493176
Probing the aggregated effects of purifying selection per individual on 1,380 medical phenotypes in the UK Biobank.
PLoS Genet
2021
33483510
An integrative multiomic network model links lipid metabolism to glucose regulation in coronary artery disease.
Nat Commun
2021
30645594
No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study.
PLoS Med
2019
31653226
HOPS: a quantitative score reveals pervasive horizontal pleiotropy in human genetic variation is driven by extreme polygenicity of human traits and diseases.
Genome Biol
2019
30478437
Reply to 'Selective effects of heterozygous protein-truncating variants'.
Nat Genet
2019
30645594
No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study.
PLoS Med
2019
30770844
Quantification of frequency-dependent genetic architectures in 25 UK Biobank traits reveals action of negative selection.
Nat Commun
2019
31653226
HOPS: a quantitative score reveals pervasive horizontal pleiotropy in human genetic variation is driven by extreme polygenicity of human traits and diseases.
Genome Biol
2019
30770844
Quantification of frequency-dependent genetic architectures in 25 UK Biobank traits reveals action of negative selection.
Nat Commun
2019
30478437
Reply to 'Selective effects of heterozygous protein-truncating variants'.
Nat Genet
2019
29388949
A literature review at genome scale: improving clinical variant assessment.
Genet Med
2018
29388949
A literature review at genome scale: improving clinical variant assessment.
Genet Med
2018
29641912
Using Full Genomic Information to Predict Disease: Breaking Down the Barriers Between Complex and Mendelian Diseases.
Annu Rev Genomics Hum Genet
2018
29641912
Using Full Genomic Information to Predict Disease: Breaking Down the Barriers Between Complex and Mendelian Diseases.
Annu Rev Genomics Hum Genet
2018
28746880
TGF-β Signaling Is Necessary and Sufficient for Pharyngeal Arch Artery Angioblast Formation.
Cell Rep
2017
28487880
When "<i>N</i> of 2" is not enough: integrating statistical and functional data in gene discovery.
Cold Spring Harb Mol Case Stud
2017
28369035
Estimating the selective effects of heterozygous protein-truncating variants from human exome data.
Nat Genet
2017
28746880
TGF-β Signaling Is Necessary and Sufficient for Pharyngeal Arch Artery Angioblast Formation.
Cell Rep
2017
28487880
When "<i>N</i> of 2" is not enough: integrating statistical and functional data in gene discovery.
Cold Spring Harb Mol Case Stud
2017
28369035
Estimating the selective effects of heterozygous protein-truncating variants from human exome data.
Nat Genet
2017
27436009
Excess of Deleterious Mutations around HLA Genes Reveals Evolutionary Cost of Balancing Selection.
Mol Biol Evol
2016
27436009
Excess of Deleterious Mutations around HLA Genes Reveals Evolutionary Cost of Balancing Selection.
Mol Biol Evol
2016
25910212
Widespread macromolecular interaction perturbations in human genetic disorders.
Cell
2015
25910212
Widespread macromolecular interaction perturbations in human genetic disorders.
Cell
2015
26509271
Disproportionate Contributions of Select Genomic Compartments and Cell Types to Genetic Risk for Coronary Artery Disease.
PLoS Genet
2015
26123021
Identification of cis-suppression of human disease mutations by comparative genomics.
Nature
2015
26378430
Mitigating false-positive associations in rare disease gene discovery.
Hum Mutat
2015
26509271
Disproportionate Contributions of Select Genomic Compartments and Cell Types to Genetic Risk for Coronary Artery Disease.
PLoS Genet
2015
26378430
Mitigating false-positive associations in rare disease gene discovery.
Hum Mutat
2015
26123021
Identification of cis-suppression of human disease mutations by comparative genomics.
Nature
2015
23315928
Predicting functional effect of human missense mutations using PolyPhen-2.
Curr Protoc Hum Genet
2013
23818451
Large numbers of genetic variants considered to be pathogenic are common in asymptomatic individuals.
Hum Mutat
2013
1 - 50 of 62
Column Actions
Search
Recommended Authors
Kymberleigh A Pagel
The Institute for Computational Medicine, The Johns Hopkins University
Career Start Year
2016
Number of shared co-authors
1
Hao Hu
Aerospace Center Hospital
Career Start Year
2011
Number of shared co-authors
4
Max Schubach
Berlin Institute of Health of Health at Charite - Universitatsmedizin Berlin
Career Start Year
2010
Number of shared co-authors
8
Hilary C Martin
Wellcome Sanger Institute
Career Start Year
2010
Number of shared co-authors
12
Seung Hoan Choi
Broad Institute of MIT and Harvard
Career Start Year
2009
Number of shared co-authors
14
John D Overton
Regeneron Pharmaceuticals
Career Start Year
2008
Number of shared co-authors
19
Graham R S Ritchie
Wellcome Sanger Institute
Career Start Year
2008
Number of shared co-authors
9
Zachary Zappala
Vertex Pharmaceuticals
Career Start Year
2008
Number of shared co-authors
14
Manuel A Rivas
Stanford University School of Medicine
Career Start Year
2008
Number of shared co-authors
28
Chad D Huff
University of Texas M.D. Anderson Cancer Center
Career Start Year
2007
Number of shared co-authors
9
William S Bush
Cleveland Institute for Computational Biology, Case Western Reserve University
Career Start Year
2006
Number of shared co-authors
11
Ali Torkamani
Scripps Science Institute
Career Start Year
2005
Number of shared co-authors
8
Benjamin F Voight
Perelman School of Medicine, University of Pennsylvania
Career Start Year
2005
Number of shared co-authors
26
Tushar Bhangale
Genentech Inc.
Career Start Year
2004
Number of shared co-authors
19
Alicia Hawes
Regeneron Pharmaceuticals Inc.
Career Start Year
2004
Number of shared co-authors
17
Joseph K Pickrell
Gencove Inc.
Career Start Year
2003
Number of shared co-authors
11
Fuli Yu
East China University of Science and Technology
Career Start Year
2002
Number of shared co-authors
20
Yufeng Shen
Columbia University
Career Start Year
2002
Number of shared co-authors
14
Andrew S Allen
Duke University School of Medicine
Career Start Year
2001
Number of shared co-authors
7
Sean D Mooney
University of Washington
Career Start Year
2001
Number of shared co-authors
5
Jessica M Maia
Institute for Genomic Medicine, Columbia University
Career Start Year
2001
Number of shared co-authors
2
Marylyn D Ritchie
Center for Systems Genomics, Pennsylvania State University, University Park
Career Start Year
2001
Number of shared co-authors
36
Paul I W de Bakker
Vertex Pharmaceuticals
Career Start Year
1999
Number of shared co-authors
36
Sebastian Z??llner
University of Michigan ann arbor
Career Start Year
1998
Number of shared co-authors
19
Sarah E Hunt
European Bioinformatics Institute
Career Start Year
1997
Number of shared co-authors
17
Andrew P Morris
The University of Manchester
Career Start Year
1997
Number of shared co-authors
34
David A Hinds
23andMe Inc.
Career Start Year
1992
Number of shared co-authors
22
Panos Deloukas
William Harvey Research Institute, Queen Mary University of London
Career Start Year
1992
Number of shared co-authors
35
Joel N Hirschhorn
Broad Institute of MIT and Harvard
Career Start Year
1988
Number of shared co-authors
35
Albert V Smith
University of Michigan School of Public Health ann arbor
Career Start Year
1987
Number of shared co-authors
40
row(s) 1 - 30 of 30
Collaborators
Ron Do
Co-authored papers
14
Shamil R Sunyaev
Harvard Medical School
Co-authored papers
13
Ghislain Rocheleau
Co-authored papers
5
Marie Verbanck
Co-authored papers
5
Girish N Nadkarni
Icahn School of Medicine at Mount Sinai
Co-authored papers
4
Hong-Hee Won
Co-authored papers
3
Noam D Beckmann
Icahn School of Medicine at Mount Sinai.
Co-authored papers
2
Kaitlin E Samocha
Co-authored papers
2
Daniel G MacArthur
Broad Institute of MIT and Harvard
Co-authored papers
2
Alexander W Charney
Icahn School of Medicine at Mount Sinai
Co-authored papers
2
Carla Marquez-Luna
Co-authored papers
2
Eimear E Kenny
Icahn School of Medicine at Mount Sinai, NY Institute for Genomic Health
Co-authored papers
2
Mark J Daly
Massachusetts General Hospital
Co-authored papers
2
Ivan Adzhubei
Co-authored papers
2
Eric E Schadt
Icahn School of Medicine at Mount Sinai
Co-authored papers
2
Anne O'Donnell-Luria
Broad Institute of MIT and Harvard
Co-authored papers
2
Birgit Funke
Partners Healthcare Center for Personalized Genetic Medicine
Co-authored papers
1
Mathieu Bourgey
McGill University
Co-authored papers
1
Albandari Binowayn
King Fahad Medical City and King Abdulaziz City for Science and Technology
Co-authored papers
1
Nattiya Hirankarn
Chulalongkorn University
Co-authored papers
1
Samantha Baxter
Broad Institute of MIT and Harvard
Co-authored papers
1
Carlos D Bustamante
Stanford University
Co-authored papers
1
Ho Namkoong
Keio University School of Medicine
Co-authored papers
1
Chiara Giannarelli
Co-authored papers
1
Mathieu Quinodoz
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Co-authored papers
1
Antonio Salas
Instituto de Investigacion Sanitaria de Santiago
Co-authored papers
1
Timothy Sanders
David Geffen School of Medicine, University of California-Los Angeles
Co-authored papers
1
Nicole Simons
Icahn School of Medicine at Mount Sinai
Co-authored papers
1
Efren Sandoval
Co-authored papers
1
Carlo Rivolta
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Co-authored papers
1
1 - 30